<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>VyvanseInfo.com &#187; Abilify</title>
	<atom:link href="http://vyvanseinfo.com/tag/abilify/feed/" rel="self" type="application/rss+xml" />
	<link>http://vyvanseinfo.com</link>
	<description>Everything you need to know about Vyvanse</description>
	<lastBuildDate>Fri, 30 Jul 2010 06:06:55 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA approves sNDA for pediatric autism drug ABILIFY (News-Medical-Net)</title>
		<link>http://vyvanseinfo.com/fda-approves-snda-for-pediatric-autism-drug-abilify-news-medical-net/</link>
		<comments>http://vyvanseinfo.com/fda-approves-snda-for-pediatric-autism-drug-abilify-news-medical-net/#comments</comments>
		<pubDate>Sat, 21 Nov 2009 04:57:18 +0000</pubDate>
		<dc:creator>Vyvanse In the News</dc:creator>
				<category><![CDATA[Vyvanse News]]></category>
		<category><![CDATA[17 Years]]></category>
		<category><![CDATA[Abilify]]></category>
		<category><![CDATA[Aggression]]></category>
		<category><![CDATA[Aripiprazole]]></category>
		<category><![CDATA[Autism]]></category>
		<category><![CDATA[Autistic Disorder]]></category>
		<category><![CDATA[Bristol Myers]]></category>
		<category><![CDATA[Bristol Myers Squibb]]></category>
		<category><![CDATA[Bristol Myers Squibb Company]]></category>
		<category><![CDATA[Drug Application]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Irritability]]></category>
		<category><![CDATA[Myers Squibb Company]]></category>
		<category><![CDATA[Otsuka Pharmaceutical Co]]></category>
		<category><![CDATA[Pediatric Patients]]></category>
		<category><![CDATA[Snda]]></category>

		<guid isPermaLink="false">http://us.rd.yahoo.com/dailynews/rss/search/vyvanse/SIG=136gjhjg6/*http%3A//www.news-medical.net/news/20091120/FDA-approves-sNDA-for-pediatric-autism-drug-ABILIFY.aspx</guid>
		<description><![CDATA[Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self ...]]></description>
			<content:encoded><![CDATA[Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self ...]]></content:encoded>
			<wfw:commentRss>http://vyvanseinfo.com/fda-approves-snda-for-pediatric-autism-drug-abilify-news-medical-net/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
